(VIANEWS) – Vaalco Energy (EGY), Progyny (PGNY), United Therapeutics Corporation (UTHR) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Vaalco Energy (EGY)
55.9% sales growth and 11.05% return on equity
VAALCO Energy, Inc., an independent energy company, acquires, explores for, develops, and produces crude oil and natural gas. The company holds Etame production sharing contract related to the Etame Marin block located offshore in the Republic of Gabon, West Africa. It also owns interests in an undeveloped block offshore Equatorial Guinea, West Africa. VAALCO Energy, Inc. was founded in 1985 and is headquartered in Houston, Texas.
Earnings Per Share
As for profitability, Vaalco Energy has a trailing twelve months EPS of $0.31.
PE Ratio
Vaalco Energy has a trailing twelve months price to earnings ratio of 13.55. Meaning, the purchaser of the share is investing $13.55 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.05%.
Sales Growth
Vaalco Energy’s sales growth is 38.9% for the ongoing quarter and 55.9% for the next.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Nov 21, 2023, the estimated forward annual dividend rate is 0.25 and the estimated forward annual dividend yield is 6.08%.
2. Progyny (PGNY)
28% sales growth and 12.06% return on equity
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Earnings Per Share
As for profitability, Progyny has a trailing twelve months EPS of $0.51.
PE Ratio
Progyny has a trailing twelve months price to earnings ratio of 59.18. Meaning, the purchaser of the share is investing $59.18 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.06%.
Volume
Today’s last reported volume for Progyny is 757844 which is 2.57% above its average volume of 738807.
Revenue Growth
Year-on-year quarterly revenue growth grew by 36.8%, now sitting on 1.03B for the twelve trailing months.
3. United Therapeutics Corporation (UTHR)
20.1% sales growth and 17.52% return on equity
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin, an infused formulation of the prostacyclin analogue treprostinil for subcutaneous and intravenous administration to diminish symptoms associated with exercise in pulmonary arterial hypertension (PAH) patients; Tyvaso, an inhaled formulation of treprostinil to enhance the exercise ability in PAH patients; Orenitram, a tablet dosage form of treprostinil to enhance the exercise capacity in PAH patients; Unituxin, a monoclonal antibody for treating high-risk neuroblastoma; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. The company also engages in developing OreniPro, RemoPro, Tyvaso DPI, Trevyent, Ralinepag, and Aurora-GT to treat PAH; Unexisome to treat bronchopulmonary dysplasia; and the research and development of various organ transplantation-related technologies, including regenerative medicine, xenotransplantation, and ex-vivo lung perfusion, as well as the development of medicine for other diseases. It has licensing and collaboration agreements with Medtronic, Inc. to develop and commercialize the implantable system for Remodulin; Caremark, L.L.C. to provide refills of implanted pumps at its infusion centers; DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of Remodulin; MannKind Corporation to develop and license treprostinil inhalation powder and Dreamboat devices; and Arena Pharmaceuticals, Inc. to develop ralinepag for the treatment of PAH. The company was incorporated in 1996 and is headquartered in Silver Spring, Maryland.
Earnings Per Share
As for profitability, United Therapeutics Corporation has a trailing twelve months EPS of $18.14.
PE Ratio
United Therapeutics Corporation has a trailing twelve months price to earnings ratio of 12.71. Meaning, the purchaser of the share is investing $12.71 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.52%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 18.1%, now sitting on 2.2B for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 55.8% and 17.5%, respectively.
Sales Growth
United Therapeutics Corporation’s sales growth is 16.7% for the ongoing quarter and 20.1% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
United Therapeutics Corporation’s EBITDA is 3.97.
4. Heritage Insurance Holdings (HRTG)
14.3% sales growth and 19.97% return on equity
Heritage Insurance Holdings, Inc., through its subsidiaries, provides personal and commercial residential insurance products. The company offers personal residential property insurance for single-family homeowners and condominium owners, and rental property insurance in the states of Alabama, California, Connecticut, Delaware, Florida, Georgia, Hawaii, Maryland, Massachusetts, Mississippi, New Jersey, New York, North Carolina, Rhode Island, South Carolina, and Virginia; commercial residential insurance for properties in Florida, New Jersey, and New York; and licensed in the state of Pennsylvania, as well as personal residential and wind-only property insurance. It also provides restoration, and emergency and recovery services; and property management, and reinsurance services. The company writes personal line policies through a network of retail independent agents, wholesale agents, and a partnership with a direct agency, as well as indirectly to approximately 1,500 retail locations through eight wholesale agency relationships; and personal and commercial insurance policies through a network of approximately 70 independent agencies. Heritage Insurance Holdings, Inc. was founded in 2012 and is headquartered in Tampa, Florida.
Earnings Per Share
As for profitability, Heritage Insurance Holdings has a trailing twelve months EPS of $0.98.
PE Ratio
Heritage Insurance Holdings has a trailing twelve months price to earnings ratio of 7.4. Meaning, the purchaser of the share is investing $7.4 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.97%.
Moving Average
Heritage Insurance Holdings’s value is way above its 50-day moving average of $5.80 and way above its 200-day moving average of $4.36.
Yearly Top and Bottom Value
Heritage Insurance Holdings’s stock is valued at $7.25 at 00:22 EST, under its 52-week high of $8.00 and way above its 52-week low of $1.31.
Revenue Growth
Year-on-year quarterly revenue growth grew by 12.6%, now sitting on 723.12M for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 14.6% and positive 9.1% for the next.
5. Opera Limited (OPRA)
11.1% sales growth and 7.37% return on equity
Opera Limited, together with its subsidiaries, provides mobile and PC web browsers. It operates in two segments, Browser and News, and Other. The company offers mobile browser products, such as Opera Mini, Opera for Android and iOS, Opera GX Mobile, and Opera Touch; PC browsers, including Opera for Computers and Opera GX; Apex Football; Opera VPN Pro; and Opera News, an AI-powered personalized news discovery and aggregation service. It also provides Opera Crypto Browser for PCs and mobile; browser-based cashback rewards; owns GameMaker Studio, a 2D gaming development platform; and GXC, a gaming portal. In addition, the company operates Opera Ads, an online advertising platform. It operates in Nigeria, Ireland, France, Germany, Spain, England, South Africa, Kenya, and internationally. The company was founded in 1995 and is headquartered in Oslo, Norway. Opera Limited is a subsidiary of Kunlun Tech Limited.
Earnings Per Share
As for profitability, Opera Limited has a trailing twelve months EPS of $0.7.
PE Ratio
Opera Limited has a trailing twelve months price to earnings ratio of 17.14. Meaning, the purchaser of the share is investing $17.14 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.37%.
6. Armada Hoffler Properties (AHH)
9.1% sales growth and 4.87% return on equity
Armada Hoffler Properties, Inc. (NYSE: AHH) is a vertically-integrated, self-managed real estate investment trust ("REIT") with four decades of experience developing, building, acquiring, and managing high-quality, institutional-grade office, retail, and multifamily properties located primarily in the Mid-Atlantic and Southeastern United States. In addition to developing and building properties for its own account, the Company also provides development and general contracting construction services to third-party clients. Founded in 1979 by Daniel A. Hoffler, the Company has elected to be taxed as a REIT for U.S. federal income tax purposes.
Earnings Per Share
As for profitability, Armada Hoffler Properties has a trailing twelve months EPS of $0.35.
PE Ratio
Armada Hoffler Properties has a trailing twelve months price to earnings ratio of 29.37. Meaning, the purchaser of the share is investing $29.37 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.87%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 31.5%, now sitting on 617.32M for the twelve trailing months.
7. Beacon Roofing Supply (BECN)
5.5% sales growth and 20.76% return on equity
Beacon Roofing Supply, Inc., together with its subsidiaries, distributes residential and non-residential roofing materials, and complementary building products to contractors, home builders, building owners, lumberyards, and retailers. It offers pitched roofing and low slope roof products; gutters and sidings; building materials, such as lumber and composite, skylights and window, plywood and OSB, decking and railing, and HVAC products; and foam board, spray foam, roll, batt, mineral wool, fiberglass, and commercial insulation products, as well as radiant barriers and blown-in insulation and equipment. The company also provides above grade and below grade membranes and coatings, deck and floor coatings, plaza deck waterproofing products, damp proofing coatings, and air and vapor barriers; tools and equipment, including power and hand tools, ladders and scaffolding, air tools and compressors, nails, screws and fasteners, generators, work wear and safety gear, job site supplies, tool bags and belts, welding and soldering, cleaning supplies, drill bits, and saw blades; and solar panels, mounting hardware, inverters, and storage and batteries. As of December 21, 2022, it operated approximately 470 branches in 50 states of the United States and 6 provinces in Canada. Beacon Roofing Supply, Inc. was founded in 1928 and is headquartered in Herndon, Virginia.
Earnings Per Share
As for profitability, Beacon Roofing Supply has a trailing twelve months EPS of $-1.03.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.76%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 17.1% and 19%, respectively.
Sales Growth
Beacon Roofing Supply’s sales growth is 12.3% for the present quarter and 5.5% for the next.
